Zobrazeno 1 - 10
of 62
pro vyhledávání: ''
Autor:
Gerd R Burmester, T. Braun, Walter Hermann, Stefan Markus Weiner, Siegfried Wassenberg, Jacqueline Detert, Pascal Klaus, Joachim Listing, Rolf Rau, Frank Buttgereit, Claudia Kedor
Publikováno v:
RMD Open
RMD Open, Vol 7, Iss 2 (2021)
RMD Open, Vol 7, Iss 2 (2021)
ObjectivesHand osteoarthritis (OA) is a condition characterised by cartilage degradation and frequently erosive changes. Analgesics and non-steroidal anti-inflammatory drugs are used for symptomatic relief but are often poorly tolerated or contraindi
Autor:
Boulos Haraoui, Shixue Liu, Rebecca Germino, Sujatha Menon, Edward C. Keystone, Tatjana Lukic, Janet E. Pope, Eduardo Mysler, Stanley Cohen, Lori Stockert, Harry Shi, Annette Diehl
Publikováno v:
RMD Open
RMD Open, Vol 7, Iss 2 (2021)
RMD Open, Vol 7, Iss 2 (2021)
ObjectivesTo report the efficacy, safety and patient-reported outcome measures (PROs) of tofacitinib modified-release 11 mg once daily plus methotrexate in patients with rheumatoid arthritis (RA) from the open-label phase of Oral Rheumatoid Arthritis
Publikováno v:
RMD Open
RMD Open, Vol 7, Iss 2 (2021)
RMD Open, Vol 7, Iss 2 (2021)
ObjectivesTo compare effectiveness between tofacitinib and tocilizumab treatments for biological disease-modifying antirheumatic drug (bDMARD)-naïve patients or previous bDMARD-failure patients with active rheumatoid arthritis (RA) refractory to met
Autor:
Stephanie Noviello, Eleni Vritzali, Jeremy Levy, Philip N. Hawkins, Ulrich A. Walker, Tom van der Poll, Hugh H. Tilson, Jasmin B Kuemmerle-Deschner, Hal M. Hoffman
Publikováno v:
RMD Open, Vol 7, Iss 2 (2021)
RMD Open
RMD open, 7(2):e001663. BMJ Publishing Group
RMD Open
RMD open, 7(2):e001663. BMJ Publishing Group
ObjectiveTo report the long-term safety and effectiveness of canakinumab, a fully human anti-interleukin 1β monoclonal antibody, in patients with cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCAS
Autor:
Qingxuan Song, Karen Leander, Iain B. McInnes, Keying Ma, Kristen Sweet, Carol Franks, Vani Lakshminarayanan, Philip Cooper, Stefan Siebert, Matthew J. Loza
Publikováno v:
RMD Open
RMD Open, Vol 7, Iss 2 (2021)
RMD Open, Vol 7, Iss 2 (2021)
ObjectiveTo investigate serum protein expression in participants with psoriatic arthritis (PsA) and changes after guselkumab treatment.MethodsParticipants with PsA were treated with guselkumab or placebo in the DISCOVER-1 and DISCOVER-2 studies. Seru
Autor:
Karim Raza, Marie Falahee
Publikováno v:
RMD Open
RMD Open, Vol 7, Iss 1 (2021)
RMD Open, Vol 7, Iss 1 (2021)
Our understanding of biological mechanisms operating at articular and extra-articular sites in individuals ‘at risk’ of rheumatoid arthritis (RA) has increased significantly over recent years.1 In parallel, there has been significant progress in
Autor:
Gunnstein Bakland, Lena Bugge Nordberg, Siri Lillegraven, Espen A Haavardsholm, Erik Rødevand, Ulf Sundin, Nina Paulshus Sundlisater, Hallvard Fremstad, Tor Magne Madland, Åse Stavland Lexberg, Hilde Haukeland, Christian Høili, Hilde Stray, Anne Noraas Bendvold, Inger W Hansen
Publikováno v:
RMD Open
RMD Open : Rheumatic & Musculoskeletal Diseases
RMD Open : Rheumatic & Musculoskeletal Diseases, BMJ, 2021, 7 (1), pp.e001539. ⟨10.1136/rmdopen-2020-001539⟩
RMD Open : Rheumatic & Musculoskeletal Diseases, EULAR ; BMJ, 2021, 7 (1), pp.e001539. ⟨10.1136/rmdopen-2020-001539⟩
RMD Open, Vol 7, Iss 1 (2021)
RMD Open : Rheumatic & Musculoskeletal Diseases
RMD Open : Rheumatic & Musculoskeletal Diseases, BMJ, 2021, 7 (1), pp.e001539. ⟨10.1136/rmdopen-2020-001539⟩
RMD Open : Rheumatic & Musculoskeletal Diseases, EULAR ; BMJ, 2021, 7 (1), pp.e001539. ⟨10.1136/rmdopen-2020-001539⟩
RMD Open, Vol 7, Iss 1 (2021)
ObjectiveThe rheumatoid arthritis impact of disease (RAID) questionnaire comprises seven patient-important domains of disease impact (pain, function, fatigue, sleep disturbance, emotional well-being, physical well-being, coping). RAID was validated a
Autor:
David H. Collier, Lyrica Liu, Bradley S. Stolshek, Joseph F. Merola, Ervant J Maksabedian Hernandez, Philip J. Mease, Gregory Kricorian, Vibeke Strand
Publikováno v:
RMD Open
RMD Open, Vol 7, Iss 1 (2021)
RMD Open, Vol 7, Iss 1 (2021)
ObjectivesWe examined patient-reported outcomes (PROs) in The Study of Etanercept And Methotrexate in Patients with Psoriatic Arthritis (PsA); a 48-week, phase 3, randomised controlled trial that compared outcomes with methotrexate (MTX) monotherapy,
Autor:
Margarita Portela-Hernández, Nilzio Antônio da Silva, Manuel F. Ugarte-Gil, Enrique R. Soriano, Loreto Massardo, M I Segami, Oscar Neira, Luis H. Silveira, Guillermo J. Pons-Estel, Mary-Carmen Amigo, Cristina Reátegui-Sokolova, Marlene Guibert-Toledano, Mónica P. Sacnun, Verónica Saurit, Rosana Quintana, Gloria Vásquez, Rosa Chacón-Diaz, Bernardo A. Pons-Estel, Eduardo Ferreira Borba Neto, Graciela S. Alarcón, María H Esteva-Spinetti, Emilia Inoue Sato, Eloisa Bonfa, Francisco Caeiro, Guillermo A. Berbotto, Alejandro Alvarellos, Daniel Wojdyla, Ana Carolina de Oliveira e Silva Montandon, Ignacio García-De La Torre, Luis J. Catoggio, Rosa M Serrano-Morales, Gil Reyes-Llerena, Mario H. Cardiel, Guillermina B Harvey, Fernando Cavalcanti, Leonor A Barile-Fabris, Mercedes A. García
Publikováno v:
RMD Open, Vol 6, Iss 3 (2020)
RMD Open
RMD Open
AimA decrease in proteinuria has been considered protective from renal damage in lupus nephritis (LN), but a cut-off point has yet to be established. The aim of this study was to identify the predictors of renal damage in patients with LN and to dete
Publikováno v:
RMD Open
RMD Open, Vol 6, Iss 2 (2020)
RMD Open, Vol 6, Iss 2 (2020)
Publisher's version (útgefin grein)
Objective: To investigate if autoimmune thyroid disease (AITD) impacts rheumatoid arthritis (RA) disease activity or response to methotrexate. Methods A nationwide register-based cohort study of 9 004 patient
Objective: To investigate if autoimmune thyroid disease (AITD) impacts rheumatoid arthritis (RA) disease activity or response to methotrexate. Methods A nationwide register-based cohort study of 9 004 patient